Vice President Corporate Business Development (Cell Therapy) - Immix Biopharma (Nasdaq: IMMX)

Vice President Corporate & Business Development (Cell Therapy)

Immix Biopharma, Inc (NASDAQ:IMMX)

Los Angeles, CA / Hybrid

Our 3 Core Values

• Intelligence
• Integrity
• Initiative

What You'll Do

• Establish and maintain strong relationships with pharmaceutical and biotech companies; identify potential strategic corporate development and business partners

• Source, screen and track business opportunities that are aligned with corporate goals and objectives by interacting with biotech, and pharma counterparts

• Lead information research and provide robust analytic and business evaluation support of corporate and business development opportunities, potential company strategies, and key business initiatives

• Develop and present robust financial models and market analyses to value projects

• Visible external liaison in the scientific and biotech communities to raise awareness of company’s partnering objectives and capabilities

• Attend strategic partnering and industry conferences related to therapeutic area of interest

• Monitor and advise the Company’s leadership on competitive intelligence and relevant developments in key indications and therapeutic areas of interest

Skills and Experience We Look For

• Bachelor’s degree or higher in biology, finance or related field with 5-10 years’ biopharma/pharmaceutical experience

• Established track record of successful strategic transactions in the biopharmaceutical industry

• Strong knowledge of biotechnology/pharmaceutical industry, drug discovery and development

• Excellent verbal and written communication skills, strong relationship management skills and strategic thinking

• Proven experience successfully supporting the scientific and business evaluation of technologies, assets, or companies in the biotechnology/pharmaceutical industry

• Demonstrated understanding of pharmaceutical product lifecycle management including drug development, FDA regulations, and commercialization paths

• Outstanding organizational, analytical, interpersonal and communication skills

• Adaptability, flexibility, and willingness to work in a changing environment

• Experience with financial analysis and/ or valuation of biopharmaceutical products and companies and advanced excel/modeling skills required

• A collaborative nature with the knowledge and understanding of the role and importance of working cross-functionally

• Self-starter, highly motivated, results-driven individual; ability to creatively solve problems

• Process-minded with the ability to operate strategically and adapt when appropriate to execute on defined goals in a timely manner

• Experience preparing and delivering presentations to senior management

• Familiarity with biopharma / pharmaceutical portfolio strategy and competitive dynamics

Rewards at Immix

Compensation commensurate with experience. Health insurance and 401k included.

About Immix Biopharma, Inc.

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated diseases. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201. NXC-201 is being evaluated in the U.S. Phase 1b/2 trial NEXICART-2 (NCT06097832) as well as the ex-U.S. study NEXICART-1 (NCT04720313). NXC-201 has demonstrated no neurotoxicity of any kind in AL Amyloidosis and short duration of cytokine release syndrome (CRS), supporting expansion into select immune-mediated diseases. NXC-201 has been awarded Orphan Drug Designation (ODD) in AL Amyloidosis by the US FDA and in the EU by the EMA. Learn more at www.immixbio.com and www.BeProactiveInAL.com.